CSL - Interest Expense On Debt

Stock Price
145.00
Daily Change
-2.38 -1.61%
Monthly
-20.73%
Yearly
-44.76%
Q1 Forecast
150.05

CSL reported $104M in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
Arca Biopharma USD 0 0 Mar/2025
Cara Therapeutics 43.75M 4.8M Jun/2025
CSL USD 104M 136M Jun/2025
Curis USD 178K 441K Dec/2023
Esperion Therapeutics USD 15.08M 1.36M Sep/2024
Immunic 400K 400K Dec/2024
Infinity Pharmaceuticals USD 45K 0 Jun/2023
Minerva Neurosciences USD 2.31M 60K Jun/2024
Sangamo BioSciences 97.56M 11.39M Jun/2025
TherapeuticsMD USD 20K 25K Sep/2023